Abstract
Immune responses to tumors are highly complex, with the final outcome dependent upon the interaction of several effector mechanisms within the immune system. Treatment of tumors, as well as other forms forms of immunological disease, has been based on use of nonphysiological agents that nonspecifically alter immunocompetent cell function. The ability of natural products of the immune system to affect immune function has been documented in many studies, in vivo and in vitro (1,2,3). Lymphokines, a group of regulatory substances produced by activated lymphocytes, have potential for development into powerful immunomodulatory tools. Research into mechanisms of lymphokine action has been hampered by lack of sufficient quantities of high purity. The number and properties of chemically distinct lymphokines is unknown. The various induction schemes used to produce lymphokines for study rarely yield a single bioactivity, and there is a strong probability that the interaction of several lymphokines is necessary to successfully modulate an immune function. Supernatants of mitogen-induced human peripheral blood lymphocyte (PBL) cultures contain several lymphokine activities. Analysis of kinetic studies has suggested a correlation in the appearance in culture supernatants of lymphotoxin activity (LT) and immune interferon (Im-IF). The interaction between LT and Im-IF was investigated in a serum-free human PBL culture system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Papermaster, B. W., C. D. Gilliland, J. E. McEntire, N. D. Rodes and P. A. Dunn. 1981. In vivo biological studies with lymphoblastoid lymphokines, p. 289–299. In A. L. Goldstein and M. A. Chirigos (eds.), Lumphokines and thymic hormones: Their potential utilization in cancer therapeutics. Raven Press, New York.
Geczy, C., A. G. Geczy and A. L. de Weck. 1976. Antibodies to guinea pig lymphokines. J. Immunol. 117: 66–72.
Khan, A., E. S. Martin, K. Webb, D. Weldon, N. O. Hill, J. Duvall and J. M. Hill. 1982. Regression of malignant melanoma in a dog by local injections of a partially purified preparation containing human a-lymphotoxin. Proc. Soc. Exp. Biol. Med. 169: 291–294.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer Science+Business Media New York
About this chapter
Cite this chapter
Robbins, C.H. (1983). Immunoregulation by Lymphokines: Immune Interferon and Lymphotoxin Induction of Lymphokine Activity in Human Peripheral Blood Leukocyte Cultures. In: Klein, T., Specter, S., Friedman, H., Szentivanyi, A. (eds) Biological Response Modifiers in Human Oncology and Immunology. Advances in Experimental Medicine and Biology, vol 166. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1410-4_4
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1410-4_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1412-8
Online ISBN: 978-1-4757-1410-4
eBook Packages: Springer Book Archive